Independent Director 2025 Annual Performance Report
As an independent director of Zhejiang Zhongxin Fluorochemical Co., Ltd. (hereinafter referred to as the "Company" or "this Company"), during my tenure, I have strictly abided by the "Company Law of the People's Republic of China" (hereinafter referred to as the "Company Law"), the "Securities Law of the People's Republic of China," the "Guiding Opinions on Regulating the Corporate Governance of Listed Companies," the "Measures for the Administration of Independent Directors of Listed Companies," the "Shenzhen Stock Exchange Stock Listing Rules," and the "Shenzhen Stock Exchange Listed Company Self-Regulatory Guidelines No. 1 - Norms for Operations of Main Board Listed Companies," and other relevant laws, regulations, and the "Company Articles of Association" and "Independent Director Work System" requirements. I have conscientiously, diligently, and loyally performed my duties, actively participated in the decision-making of the Company's major matters, fully utilized the role of independent director, and effectively protected the overall interests of the Company and the legitimate rights and interests of all shareholders, especially small and medium shareholders. The performance of my duties in 2025 is reported as follows:
I. Basic Information of Independent Directors
(I) Personal Information
Ni Xueming: Male, born in April 1984, Chinese national, with no overseas permanent residency. Holds a Ph.D. in Applied Economics from Tsinghua University and completed a postdoctoral fellowship in Mathematics at the Chinese Academy of Sciences. His main research areas include private equity and venture capital, quantitative finance, and financial technology. He has published over sixty papers in core journals and authored eight books. He previously served as an independent director for Zhejiang Huace Film & TV Co., Ltd., Zhejiang Hanghua Technology Co., Ltd. (New Third Board, terminated listing), Zhejiang Yunzhongma Co., Ltd., and Wuxi Sunshine Machinery Co., Ltd. (New Third Board). He is currently an associate professor at the School of Software and Microelectronics, Peking University (Department of Financial Information and Engineering Management) and an independent director for Beijing Shougang Jintai'an New Materials Co., Ltd. (unlisted). He has served as an independent director of this Company since August 2022.
(II) Explanation of Circumstances Affecting Independence
As an independent director of the Company, I do not hold any positions in the Company other than that of an independent director. Neither I nor my lineal relatives or main social connections are employed by the Company or its affiliated enterprises. Furthermore, I do not provide financial, legal, or consulting services to the Company or its controlling shareholders or their respective affiliated enterprises. There are no circumstances that hinder my independent and objective judgment, nor are there any violations of the independence requirements for independent directors as stipulated in Article 6 of the "Measures for the Administration of Independent Directors of Listed Companies."
II. Performance of Independent Director Duties in the Reporting Year
(I) Attendance at Meetings
In 2025, the Company held 9 board meetings and 3 shareholder meetings, all conducted through on-site combined with communication methods. As an independent director, with a diligent and responsible attitude, I actively participated in the board meetings, shareholder meetings, and special committees convened by the Company. When reviewing matters submitted to the board, especially major matters, I maintained close communication with the Company and relevant parties, carefully reviewed relevant materials, thoroughly deliberated on each proposal, and fully utilized my professional knowledge, combined with the Company's operational reality, to exercise independent director powers objectively, independently, and prudently, thereby ensuring the scientific decision-making of the Company's board. During the reporting period, there were no instances of unexcused absences or consecutive absences from personal attendance at meetings. During the reporting period, I voted in favor of all proposals at the board meetings in 2025, with no dissenting opinions, reservations, or inability to express opinions. The details of my attendance at board and shareholder meetings in 2025 are as follows: